CU20130141A7 - TRIAZOLOPIRIDINS - Google Patents

TRIAZOLOPIRIDINS

Info

Publication number
CU20130141A7
CU20130141A7 CU2013000141A CU20130141A CU20130141A7 CU 20130141 A7 CU20130141 A7 CU 20130141A7 CU 2013000141 A CU2013000141 A CU 2013000141A CU 20130141 A CU20130141 A CU 20130141A CU 20130141 A7 CU20130141 A7 CU 20130141A7
Authority
CU
Cuba
Prior art keywords
compounds
preparing
triazolopiridins
prophylaxis
disease
Prior art date
Application number
CU2013000141A
Other languages
Spanish (es)
Other versions
CU24174B1 (en
Inventor
Volker Schulze
Dirk Kosemund
Antje Margret Wengner
Gerhard Siemeister
Detlef Stöckigt
Philip Lienau
Hartmut Schirok
Hans Briem
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Priority claimed from PCT/EP2012/056914 external-priority patent/WO2012143329A1/en
Publication of CU20130141A7 publication Critical patent/CU20130141A7/en
Publication of CU24174B1 publication Critical patent/CU24174B1/en

Links

Abstract

Compuestos de triazolopiridina de la fórmula general (I) donde R^1, R^2, R^3, R^4 y R^5 tienen los valores que se definen en la descrpción y en las reinvindicaciones. Métodos para preparar dichos compuestos. Composiciones y combinaciones farmacéuticas que comprenden dichos compuestos. Uso de dichos compuestos para preparar una composición farmacéuticamente para el tratamiento o la profilaxis de una enfermedad. Compuestos intermediarios útiles para preparar dichos compuestos.Triazolopyridine compounds of the general formula (I) where R ^ 1, R ^ 2, R ^ 3, R ^ 4 and R ^ 5 have the values defined in the description and in the claims. Methods for preparing said compounds. Compositions and pharmaceutical combinations comprising said compounds. Use of said compounds to prepare a pharmaceutical composition for the treatment or prophylaxis of a disease. Intermediate compounds useful for preparing said compounds.

CUP2013000141A 2011-04-21 2012-04-16 TRIAZOLOPIRIDINS AS QUINASE INHIBITORS MPS-1 CU24174B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11163342 2011-04-21
EP11167872 2011-05-27
PCT/EP2012/056914 WO2012143329A1 (en) 2011-04-21 2012-04-16 Triazolopyridines

Publications (2)

Publication Number Publication Date
CU20130141A7 true CU20130141A7 (en) 2014-03-26
CU24174B1 CU24174B1 (en) 2016-04-25

Family

ID=52394781

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2013000141A CU24174B1 (en) 2011-04-21 2012-04-16 TRIAZOLOPIRIDINS AS QUINASE INHIBITORS MPS-1

Country Status (2)

Country Link
CU (1) CU24174B1 (en)
TN (1) TN2013000426A1 (en)

Also Published As

Publication number Publication date
CU24174B1 (en) 2016-04-25
TN2013000426A1 (en) 2015-03-30

Similar Documents

Publication Publication Date Title
CU20140068A7 (en) SUBSTITUTED TRIAZOLOPIRIDINS
CU20120171A7 (en) SUBSTITUTED TRIAZOLOPIRIDINS
ECSP13013011A (en) TRIAZOLOPIRIDINS
DOP2012000150A (en) TRIAZOLOPIRIDINS
CY1124855T1 (en) 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
NI201500142A (en) 3-ACETYLAMINO-1 (PHENYL-HETEROARIL-AMINOCARBONIL OR PHENYL-HETEROARYL-CARBONYLAMINE) DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
CL2014001158A1 (en) Alkylated piperazine derivative compounds; pharmaceutical composition that includes them; process to prepare the pharmaceutical composition; kit and use in the treatment of immune disorders, cancer, cardiovascular diseases, inflammation, among others.
GT201400136A (en) COMPOUNDS AND METHODS OF BENZALDEHYDE SUBSTITUTED FOR USE IN INCREASING OXYGENATION OF FABRICS
CL2013002417A1 (en) Compounds derived from fluoropyridinone; pharmaceutical composition comprising them; and its use in the treatment of bacterial infections.
CO6620055A2 (en) Certain amino-pyrimidines, compositions thereof and methods for the use thereof
UY35040A (en) PIRROLOPIRIMIDINILAMINO-BENZOTIAZOLONAS REPLACED
CR20160016A (en) SUBSTITUTED PIRAZOLPIRIDINS
UY32153A (en) PY13KA (ALFA) AND MTOR PYRIDOMIDINONE INHIBITORS
SV2017005466A (en) PIRAZOLPIRIDINAMINS AS INHIBITORS OF MKNK1 AND MKNK2
UY34854A (en) GLUCOSE TRANSPORTATION INHIBITORS
AR089269A1 (en) COMPOSITIONS FOR ORAL CARE
CR20150653A (en) NEW COMPOUNDS FOR CANCER TREATMENT
CL2013001945A1 (en) Pyrazole-derived compounds of formulas (ia) or (ib), crth2 antagonists; pharmaceutical compositions containing them; pharmaceutical combinations; its use in the prevention and / or treatment of inflammatory, infectious and immunoregulatory disorders.
SV2010003773A (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME
CL2011003123A1 (en) Substituted cyclopentanamide derived compounds; pharmaceutical composition; obtaining process; and use in the treatment or prophylaxis of diabetes, atherosclerosis, among others.
ECSP13012988A (en) DERIVATIVES OF TIENOPIRIMIDINE (2,3-D) AND ITS USE TO TREAT ARRITMIA
CU20130141A7 (en) TRIAZOLOPIRIDINS
CL2011003355A1 (en) Compounds derived from alkoxycarbonyl-amino-alkynyl-adenosine; pharmaceutical composition comprising them; use of the compound in the preparation of a useful medicine to treat autoimmune, inflammatory, allergic, infectious diseases among others.
CL2011001916A1 (en) Use of ezatiostat or a salt of it for the treatment of myelodysplasic syndrome; pharmaceutical composition comprising said compound in addition to lenalidomide; pharmaceutical combination; Pharmaceutical kit

Legal Events

Date Code Title Description
FG Grant of patent